Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PMCB PharmaCyte Biotech > Detailed Quotes

PMCB PharmaCyte Biotech

2.4000.0000.00%
Close 09/30 16:00 ET
2.290
-0.110-4.58%
Post Mkt Price 09/30 16:18 ET
High
2.470
Open
2.400
Turnover
53.68K
Low
2.400
Pre Close
2.400
Volume
22.14K
Market Cap
49.80M
P/E(TTM)
8.00
52wk High
3.220
Shares
20.75M
P/E(Static)
Loss
52wk Low
1.790
Float Cap
39.45M
Bid/Ask %
-60.00%
Historical High
9.980
Shs Float
16.44M
Volume Ratio
0.18
Historical Low
1.790
Dividend TTM
--
Div Yield TTM
--
P/B
0.58
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.14%
Amplitude
2.92%
Avg Price
2.424
Lot Size
1
Float Cap
39.45M
Bid/Ask %
-60.00%
Historical High
9.980
Shs Float
16.44M
Volume Ratio
0.18
Historical Low
1.790
Dividend TTM
--
P/B
0.58
Dividend LFY
--
Turnover Ratio
0.14%
Amplitude
2.92%
Avg Price
2.424
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.
CEO: Mr. Kenneth L. Waggoner
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...